glp-1 news today receptor agonists show promise in treating substance use disorders As interest in GLP-1 medication

Civilian doctors who evaluate and treat Service Members for obesity may prescribe anti-obesity medications (such as semaglutide and tirzepatide) but should be familiar with the TRICARE coverage algorithm

Offer is not eligible with other promo codes or other discounts

Medicare has long-been prohibited by law from covering medications used specifically for weight loss but covers GLP-1 drugs for other approved conditions like type 2 diabetes

Important safety considerations include the risk of pancreatitis (all GLP-1 agonists carry warnings about this), gallbladder disease (more common with greater weight loss), and a caution with semaglutide in patients with pre-existing diabetic retinopathy, where rapid improvement in glucose control may temporarily worsen retinopathy